|
|
|
Scientific Literature, autoimmune disease
-
Aaltonen J, Bjorses P 1999 Cloning of the APECED gene provides new insight into human autoimmunity.
Ann. Med. 31: 111-116.
-
Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J 2008 Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes.
Diabetologia 51: 769-772.
*
-
Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A 2007 Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.
J. Clin. Endocrinol. Metab. 92: S1-S47.
-
Abanmi A, Al Harthi F, Zouman A, Kudwah A, Jamal MA, Arfin M, Tariq M 2008 Association of interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo.
Dis. Markers 24: 51-57.
-
Abbas AK, Lohr J, Knoechel B 2007 Balancing autoaggressive and protective T cell responses.
J. Autoimmun. 28: 59-61.
-
Abbas AK, Lohr J, Knoechel B, Nagabhushanam V 2004 T cell tolerance and autoimmunity.
Autoimmun. Rev. 3: 471-475.
-
Abbas Z, Jafri W, Rasool S, Abid S, Hameed I 2007 Mucormycosis in patients with complicated cirrhosis.
Singapore Med. J. 48: 69-73.
*
-
Abbasi SY, Milhem M, Zaru L 2008 A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.
Ann. Hematol. 87: 459-462.
-
Abbott DW, Wilkins A, Asara JM, Cantley LC 2004 The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
Curr. Biol. 14: 2217-2227.
*
-
Abdalian R, Heathcote EJ 2006 Sclerosing cholangitis: a focus on secondary causes.
Hepatology 44: 1063-1074.
*
-
Abdo AA, Bain VG, Kichian K, Lee SS 2002 Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome.
Hepatology 36: 1393-1399.
*
-
Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, Heuvelmans-Jacobs M, Akira S, Nicklin MJ, Ribeiro-Dias F, van den Berg WB 2008 Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.
J. Clin. Invest. 118: 205-216.
*
-
Abdul-Aziz K, Faizal AA 2005 Serological diagnosis of autoimmune hepatobiliary diseases.
Saudi Med. J. 26: 1875-1881.
-
Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S 2005 Effect of linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Int. Immunopharmacol. 5: 231-239.
-
Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG 2007 CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis.
Ann. N. Y. Acad. Sci. 1107: 22-31.
-
Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG 2008 Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
Arthritis Rheum. 58: 2196-2205.
*
-
Abdullah MA 2005 Epidemiology of type I diabetes mellitus among Arab children.
Saudi Med. J. 26: 911-917.
-
Abe H, Tsuboi N, Yukawa S, Tsuji S, Hayashi H, Yukawa N, Takanashi H, Tahara K, Tonozuka N, Hayashi T 2004 Thrombotic thrombocytopenic purpura complicating Sjogren's syndrome with crescentic glomerulonephritis and membranous nephritis.
Mod. Rheumatol. 14: 174-178.
-
Abe K, Saito H, Takahashi A, Rai T, Takiguchi J, Kanno Y, Monoe K, Ohira H 2007 A case of acute hepatitis associated with Basedow's disease.
Nippon Shokakibyo Gakkai Zasshi 104: 52-56.
-
Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto K, Horiike N, Onji M 2003 Drug-induced hepatitis with autoimmune features during minocycline therapy.
Intern. Med. 42: 48-52.
*
-
Abe M, Thomson AW 2006 Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death.
Clin. Immunol. 118: 300-306.
*
-
Abe R 2005 Regulation of immune response by T cell co-signaling.
Nihon Rinsho Meneki Gakkai Kaishi 28: 21-32.
-
Abe S, Hanawa H, Hayashi M, Yoshida T, Komura S, Watanabe R, Lie H, Chang H, Kato K, Kodama M, Maruyama H, Nakazawa M, Miyazaki J, Aizawa Y 2005 Prevention of experimental autoimmune myocarditis by hydrodynamics-based naked plasmid DNA encoding CTLA4-Ig gene delivery.
J. Card. Fail. 11: 557-564.
-
Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H, Sakamaki H, Kawasaki E, Awata T, Yamaguchi Y, Eguchi K 1999 CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes.
Diabetes Res. Clin. Pract. 46: 169-175.
-
Abebe F, Mustafa T, Nerland AH, Bjune GA 2006 Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.
Clin. Exp. Immunol. 143: 180-192.
*
-
Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, Depierre JW, Hassan M 2005 Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice.
Clin. Exp. Immunol. 141: 238-247.
*
-
Abel B, Kurrer M, Shamshiev A, Marty RR, Eriksson U, Gunthert U, Kopf M 2006 The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis.
Eur. J. Immunol. 36: 494-499.
*
-
Abel M, Cellier C, Kumar N, Cerf-Bensussan N, Schmitz J, Caillat-Zucman S 2006 Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism.
Hum. Immunol. 67: 612-617.
-
Abenavoli L, Proietti I, Leggio L, Ferrulli A, Vonghia L, Capizzi R, Rotoli M, Amerio PL, Gasbarrini G, Addolorato G 2006 Cutaneous manifestations in celiac disease.
World J. Gastroenterol. 12: 843-852.
*
-
Abiru N, Kawasaki E, Eguch K 2002 Current knowledge of Japanese type 1 diabetic syndrome.
Diabetes Metab. Res. Rev. 18: 357-366.
*
-
Abo T, Kawamura T, Watanabe H 2005 Immunologic states of autoimmune diseases.
Immunol. Res. 33: 23-34.
-
Abou-Raya A, Abou-Raya S 2006 Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
Autoimmun. Rev. 5: 331-337.
-
Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H 2007 Chronic inflammatory autoimmune disorders and atherosclerosis.
Ann. N. Y. Acad. Sci. 1107: 56-67.
*
-
Aboul-Enein F, Weiser P, Hoftberger R, Lassmann H, Bradl M 2006 Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis.
Acta Neuropathol. (Berl.) 111: 539-547.
-
Abraham C, Hart J, Locke SM, Baker AL 2008 A case of indometacin-induced acute hepatitis developing into chronic autoimmune hepatitis.
Nat. Clin. Pract. Gastroenterol. Hepatol. 5: 172-176.
*
-
Abraham D, Dashwood M 2008 Endothelin - role in vascular disease.
Rheumatology (Oxford) 47 Suppl. 5: v23-v24.
-
Abraham DJ, Varga J 2005 Scleroderma: from cell and molecular mechanisms to disease models.
Trends Immunol. 26: 587-595.
*
-
Abraham LJ, Kroeger KM 1999 Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease.
J. Leukoc. Biol. 66: 562-566.
*
-
Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner HL 2008 In vitro induction of regulatory T cells by anti-CD3 antibody in humans.
J. Autoimmun. 30: 21-28.
*
-
Abraham S, Begum S, Isenberg D 2004 Hepatic manifestations of autoimmune rheumatic diseases.
Ann. Rheum. Dis. 63: 123-129.
*
-
Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT 2008 Significance of central perivenulitis in pediatric liver transplantation.
Am. J. Surg. Pathol. Aug 12 [Epub ahead of print].
-
Abraham SC, Kamath PS, Eghtesad B, Demetris AJ, Krasinskas AM 2006 Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Am. J. Surg. Pathol. 30: 1454-1461.
-
Abrams B 2005 Long-term sleep apnea as a pathogenic factor for cell-mediated autoimmune disease.
Med. Hypotheses 65: 1024-1027.
-
Abreu MT 2002 The pathogenesis of inflammatory bowel disease: translational implications for clinicians.
Curr. Gastroenterol. Rep. 4: 481-489.
-
Abromson-Leeman S, Ladell DS, Bronson RT, Dorf ME 2007 Heterogeneity of EAE mediated by multiple distinct T-effector subsets.
J. Neuroimmunol. 192: 3-12.
*
-
Abu-Amer Y, Darwech I, Otero J 2008 Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.
Autoimmunity 41: 204-211.
-
Abu-Mouch S, Selmi C, Benson GD, Kenny TP, Invernizzi P, Zuin M, Podda M, Rossaro L, Gershwin ME 2003 Geographic clusters of primary biliary cirrhosis.
Clin. Dev. Immunol. 10: 127-131.
*
-
Abuzeid WM, Ruckenstein MJ 2008 Spirochetes in otology: are we testing for the right pathogens?
Otolaryngol. Head Neck Surg. 138: 107-109.
-
Acevedo-Suarez CA, Hulbert C, Woodward EJ, Thomas JW 2005 Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.
J. Immunol. 174: 827-833.
*
-
Acha-Orbea H 1991 Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
Res. Immunol. 142: 487-490.
-
Achenbach P, Fuchtenbusch M 2004 Modulating the autoimmune response in type 1 diabetes: a report on the 64th Scientific Sessions of the ADA, June 2004, Orlando, FL, USA.
Rev. Diabet. Stud. 1: 137-140.
*
-
Ackerman LS 2006 Sex hormones and the genesis of autoimmunity.
Arch. Dermatol. 142: 371-376.
*
-
Ackermann C, Kavanaugh A 2007 Tumor necrosis factor as a therapeutic target of rheumatologic disease.
Expert Opin. Ther. Targets 11: 1369-1384.
-
Ackermann C, Kavanaugh A 2008 Economic burden of psoriatic arthritis.
Pharmacoeconomics 26: 121-129.
-
Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F 2007 Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.
Nat. Immunol. 8: 942-949.
*
-
Actis GC, Ottobrelli A, Baldi S, Scappaticci E, Modena V, Fusaro E, Mengozzi G, Rizzetto M 2005 Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
Mt. Sinai J. Med. 72: 136-140.
*
-
Actis GC, Pellicano R, Bugianesi E, Lagget M, Rizzetto M 2008 Use of corticosteroids, immunomodulators, and Infliximab at a third-level day-hospital service of gastro-hepatology.
Minerva Gastroenterol. Dietol. 54: 239-242.
-
Acuna OM, Athannassaki I, Paysse EA 2007 Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease.
Trans. Am. Ophthalmol. Soc. 105: 146-151.
*
-
Adachi T, Matsushita T, Ichihashi R, Hirashima K, Ito M, Inukai A, Yokozawa T, Nishida T, Murata M, Hayashi M, Katsumi A, Kojima T, Saito H, Naoe T 2006 High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation.
Int. J. Hematol. 83: 415-419.
-
Adam AC, Grohe C, Stier S, Gattenlohner S, Balta Z, Buttner R, Gutgemann I 2007 Hodgkin's lymphoma in a patient with Jo-1 syndrome.
Virchows Arch. 451: 101-104.
*
-
Adam O 2008 Ankylosing spondylitis and convenient nutrition.
Wien. Med. Wochenschr. 158: 294-297.
-
Adam P, Haralambieva E, Ott G 2007 Extranodal marginal zone B-cell lymphoma of MALT-type.
Pathologe 28: 6-14.
-
Adams DD 1969 A study of the pathogenesis of rheumatic fever, glomerulonephritis and other autoimmune diseases triggered by infection.
Clin. Exp. Immunol. 5: 105-115.
*
-
Adams DD, Knight JG 2003 Principles of autoimmune disease: pathogenesis, genetics and specific immunotherapy.
J. Clin. Lab. Immunol. 52: 1-22.
-
Adams DD, Knight JG, Manning P, Smith G 2005 An informative case of Graves' disease with implications for schizophrenia.
J. Clin. Lab. Immunol. 53: 13-25.
-
Adams DH, Afford SC, Lalor PF 2003 Cellular immunoreactions in the development of primary biliary cirrhosis.
Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 27. October 15-16. *
-
Adams DH, Eksteen B, Grant A 2007 Entero-hepatic lymphocyte homing and liver manifestations of IBD.
Falk Symposium 162. LIVER CIRRHOSIS: FROM PATHOPHYSIOLOGY TO DISEASE MANAGEMENT. Dresden (Germany) October 13-14, 2007, p. 20-21.
-
Adams JE, Webb MS, Hu X, Staunton D, Barnum SR 2007 Disruption of the beta(2)-integrin CD11d (alpha(D)beta2) gene fails to protect against experimental autoimmune encephalomyelitis.
J. Neuroimmunol. 184: 180-187.
-
Adams JM, Cory S 2007 Bcl-2-regulated apoptosis: mechanism and therapeutic potential.
Curr. Opin. Immunol. 19: 488-496.
-
Adams KM, Nelson JL 2004 Microchimerism: an investigative frontier in autoimmunity and transplantation.
JAMA 291: 1127-1131.
*
-
Adams LA, Lindor KD, Angulo P 2004 The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease.
Am. J. Gastroenterol. 99: 1316-1320.
*
-
Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K 2007 The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.
J. Exp. Med. 204: 571-582.
*
-
Adams RW, Chapman RL, Smallwood GA 2001 Steroid withdrawal in liver transplant recipients.
Prog. Transplant. 11: 217-223.
-
Adamson KA, Pearce SH, Lamb JR, Seckl JR, Howie SE 2004 A comparative study of mRNA and protein expression of the autoimmune regulator gene (Aire) in embryonic and adult murine tissues.
J. Pathol. 202: 180-187.
*
-
Adar T, Ilan Y 2008 beta-Glycosphingolipids as immune modulators.
J. Immunotoxicol. 5: 209-220.
-
Adarichev VA, Bardos T, Christodoulou S, T Phillips M, Mikecz K, Glant TT 2002 Major histocompatibility complex controls susceptibility and dominant inheritance, but not the severity of the disease in mouse models of rheumatoid arthritis.
Immunogenetics 54: 184-192.
*
-
Adarichev VA, Vegvari A, Szabo Z, Kis-Toth K, Mikecz K, Glant TT 2008 Congenic strains displaying similar clinical phenotype of arthritis represent different immunologic models of inflammation.
Genes Immun. Jul 24 [Epub ahead of print].
-
Adarichev VA, Vermes C, Hanyecz A, Ludanyi K, Tunyogi-Csapo M, Finnegan A, Mikecz K, Glant TT 2006 Antigen-induced differential gene expression in lymphocytes and gene expression profile in synovium prior to the onset of arthritis.
Autoimmunity 39: 663-673.
-
Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT 2005 Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation.
Arthritis Res. Ther. 7: R196-R207.
*
-
Ader F, Chatellier D, Le Berre R, Morand P, Fourrier F 2006 Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject.
Med. Mal. Infect. 36: 396-398.
-
Adhami E 2004 Calculating the etiology of systemic lupus erythematosus.
Med. Hypotheses 62: 237-246.
-
Adibhatla RM, Hatcher JF 2008 Altered lipid metabolism in brain injury and disorders.
Subcell. Biochem. 48: nihpa41041.
*
-
Adibhatla RM, Hatcher JF 2008 Altered lipid metabolism in brain injury and disorders.
Subcell. Biochem. 49: 241-268.
-
Adler EM 2004 Focus issue - tailoring the immune response.
Sci. STKE 241: EG9.
*
-
Adler G 2005 The posttranslational modification of thyrotropin receptor and thyroid diseases.
Endokrynol. Pol. 56: 72-77.
-
Adlesic M, Verdrengh M, Bokarewa M, Dahlberg L, Foster SJ, Tarkowski A 2007 Histamine in rheumatoid arthritis.
Scand. J. Immunol. 65: 530-537.
*
-
Adorini L 2000 New trends in clinical and experimental immunosuppression - fourth international conference.
IDrugs 3: 496-498.
-
Adorini L 2005 Intervention in autoimmunity: the potential of vitamin D receptor agonists.
Cell. Immunol. 233: 115-124.
*
-
Adorini L 2002 Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.
Int. Immunopharmacol. 2: 1017-1028.
-
Adorini L 2004 Antigen-based immunointervention in human autoimmune diseases.
Trends Biotechnol. 22: 547-549.
*
-
Adorini L, Penna G 2008 Control of autoimmune diseases by the vitamin D endocrine system.
Nat. Clin. Pract. Rheumatol. 4: 404-412.
-
Adorini L, Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Fibbi B, Morelli A, Uskokovic M, Colli E, Maggi M 2007 Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol).
J. Steroid Biochem. Mol. Biol. 103: 689-693.
-
Adriani M, Aoki J, Horai R, Thornton AM, Konno A, Kirby M, Anderson SM, Siegel RM, Candotti F, Schwartzberg PL 2007 Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
Clin. Immunol. 124: 41-48.
*
-
Adsay NV, Basturk O, Thirabanjasak D 2005 Diagnostic features and differential diagnosis of autoimmune pancreatitis.
Semin. Diagn. Pathol. 22: 309-317.
-
Aftab MN, Dee A, Helm TN 2006 Erythema elevatum diutinum arising in the setting of dermatitis herpetiformis.
Cutis 78: 129-132.
-
Afzali B, Lombardi G, Lechler RI, Lord GM 2007 The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.
Clin. Exp. Immunol. 148: 32-46.
*
-
Agarwal K, Czaja AJ, Jones DE, Donaldson PT 2000 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Hepatology 31: 49-53.
*
-
Agarwal K, Jones DE, Bassendine MF 1999 Genetic susceptibility to primary biliary cirrhosis.
Eur. J. Gastroenterol. Hepatol. 11: 603-606.
-
Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF 2000 CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis.
J. Hepatol. 32: 538-541.
*
-
Agarwal K, Jones DE, Watt FE, Burt AD, Floreani A, Bassendine MF 2002 Familial primary biliary cirrhosis and autoimmune cholangitis.
Dig. Liver Dis. 34: 50-52.
-
Agarwal RK, Horai R, Viley AM, Silver PB, Grajewski RS, Bo Su S, Yazdani AT, Zhu W, Kronenberg M, Murray PJ, Rutschman RL, Chan CC, Caspi RR 2008 Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.
J. Immunol. 180: 5423-5429.
-
Agate L, Mariotti S, Elisei R, Mossa P, Pacini F, Molinaro E, Grasso L, Masserini L, Mokhort T, Vorontsova T, Arynchyn A, Tronko MD, Tsyb A, Feldt-Rasmussen U, Juul A, Pinchera A 2008 Thyroid autoantibodies (ATA) and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease.
J. Clin. Endocrinol. Metab. 93: 2729-2736.
*
-
Aggarwal A, Catlett JP 2002 Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
South. Med. J. 95: 1209-1212.
-
Aggarwal BB 2003 Signalling pathways of the TNF superfamily: a double-edged sword.
Nat. Rev. Immunol. 3: 745-756.
*
-
Aggarwal BB, Harikumar KB 2008 Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.
Int. J. Biochem. Cell. Biol. Jul 9 [Epub ahead of print].
*
-
Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P 2008 Potential of spice-derived phytochemicals for cancer prevention.
Planta Med. Jul 8 [Epub ahead of print].
-
Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H 2006 TNF blockade: an inflammatory issue.
Ernst Schering Res. Found. Workshop 56: 161-186.
-
Aggarwal C, Gupta S, Hahn T, Smiley S, Padmanabhan S, McCarthy PL Jr, Battiwalla M 2008 Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies.
Leuk. Lymphoma 49: 1494-1500.
-
Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, Parvaneh N, Abolhassani H, Pourpak Z, Moin M 2008 IgA deficiency: correlation between clinical and immunological phenotypes.
J. Clin. Immunol. Aug 6 [Epub ahead of print].
*
-
Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, Hammarstrom L 2008 Progression of selective IgA deficiency to common variable immunodeficiency.
Int. Arch. Allergy Immunol. 147: 87-92.
-
Aghdami N, Gharibdoost F, Moazzeni SM 2008 Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route.
Exp. Anim. 57: 45-55.
-
Agmon-Levin N, Elbirt D, Sthoeger ZM 2008 Immune reconstitution inflammatory syndrome in human immunodeficiency (HIV) infected patients.
Harefuah 147: 439-444, 476, 477.
-
Agoston-Coldea L, Fodor D, Pais R, Rusu ML, Georgiu C 2002 Autoimmune cholangitis in patients with primary Sjogren's syndrome. A case report.
Rom. J. Gastroenterol. 11: 321-324.
-
Agrawal N, Chiang LK, Rifkin IR 2006 Lupus nephritis.
Semin. Nephrol. 26: 95-104.
-
Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A 2001 MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
Tissue Antigens 58: 335-338.
*
-
Aguillon JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M 2006 Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?
Immunobiology 211: 75-84.
-
Aguillon JC, Cruzat A, Cuenca J, Cuchacovich M 2002 Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease.
Rev. Med. Chil. 130: 1043-1050.
-
Aguirre S, Silber AM, Brito ME, Ribone ME, Lagier CM, Marcipar IS 2006 Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.
J. Clin. Microbiol. 44: 3768-3774.
*
-
Ahangari G, Naderimanesh H, Hossein-Nezhad A, Zouali M 2008 A novel tissue engineering-based assay for immunological infertility.
Scand. J. Immunol. 68: 463-468.
*
-
Aharoni R, Herschkovitz A, Eilam R, Blumberg-Hazan M, Sela M, Bruck W, Arnon R 2008 Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
Proc. Natl. Acad. Sci. U.S.A. 105: 11358-11363.
-
Aharonowiz M, Einstein O, Fainstein N, Lassmann H, Reubinoff B, Ben-Hur T 2008 Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.
PLoS ONE 3: e3145.
*
-
Ahlemann M, Schmitt B, Stieber P, Gires O, Lang S, Zeidler R 2006 Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations.
Anticancer Res. 26: 783-789.
-
Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP 2004 Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
Am. J. Hematol. 77: 171-176.
*
-
Ahmad YA, Bruce IN 2001 Genetic epidemiology: systemic lupus erythematosus.
Arthritis Res. 3: 331-336.
*
-
Ahmadi K, McCruden AB 2005 Macrophage may responses to androgen via its receptor.
Med. Sci. Monit. 12: BR15-BR20.
*
-
Ahmed AM, Barahmani N, Duvic M; National Alopecia Areata Registry 2008 Familial alopecia areata and chronic thrombocytopenia.
J. Am. Acad. Dermatol. 58: S75-S77.
-
Ahmed I, Harshad SR 2006 Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?
J. Am. Acad. Dermatol. 54: 55-60.
-
Ahmed I, Nasreen S, Bhatti R 2007 Alopecia areata in children.
J. Coll. Physicians Surg. Pak. 17: 587-590.
-
Ahmed MM, Berney SM, Wolf RE, Hearth-Holmes M, Hayat S, Mubashir E, Vanderheyde H, Chang WL, King JW 2006 Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus.
Am. J. Med. Sci. 331: 252-256.
-
Ahmed SS, Tan FK 2003 Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations.
Curr. Opin. Rheumatol. 15: 766-771.
-
Ahn ER, Lander G, Bidot CJ, Jy W, Ahn YS 2005 Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy.
Am. J. Hematol. 78: 127-129.
*
-
Ahn J, Flamm SL, Flamm SL 2005 Autoimmune hepatitis.
Curr. Treat. Options Gastroenterol. 8: 481-492.
-
Ahn JH, Kim TH, Peck KR, Song YW 1993 A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine.
Korean J. Intern. Med. 8: 46-50.
-
Ahn KS, Sethi G, Aggarwal BB 2007 Nuclear factor-kappa B: from clone to clinic.
Curr. Mol. Med. 7: 619-637.
-
Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH, Oh YH, Park YM 2004 Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB.
Biochem. Biophys. Res. Commun. 313: 148-155.
*
-
Ahn SY, Ingulli E 2008 Acute poststreptococcal glomerulonephritis: an update.
Curr. Opin. Pediatr. 20: 157-162.
-
Ahrens ET, Flores R, Xu H, Morel PA 2005 In vivo imaging platform for tracking immunotherapeutic cells.
Nat. Biotechnol. 23: 983-987.
*
-
Ahrens ET, Morel PA 2005 In vivo imaging of autoimmune disease in model systems.
Curr. Top. Dev. Biol. 70C: 215-238.
-
Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ 2007 Depletion of B cells in murine lupus: efficacy and resistance.
J. Immunol. 179: 3351-3361.
*
-
Ahya SN, Jose Soler M, Levitsky J, Batlle D 2006 Acid-base and potassium disorders in liver disease.
Semin. Nephrol. 26: 466-470.
-
Airaghi L, Tedeschi A 2006 Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level.
Acta Diabetol. 43: 43-45.
*
-
Airas L, Saraste M, Rinta S, Elovaara I, Huang YH, Wiendl H; The Finnish Multiple Sclerosis and Pregnancy Study Group 2008 Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells.
Clin. Exp. Immunol. 151: 235-243.
-
Aires da Silva F, Corte-Real S, Goncalves J 2008 Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs.
BioDrugs 22: 301-314.
-
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB 2004 Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients.
Am. J. Gastroenterol. 99: 432-441.
*
-
Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT 2006 Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans.
Nature 439: 851-855.
*
-
Aittoniemi J, Baer M, Soppi E, Vesikari T, Miettinen A 1998 Mannan binding lectin deficiency and concomitant immunodefects.
Arch. Dis. Child. 78: 245-248.
*
-
Aittoniemi J, Turpeinen H, Tiittanen M, Knip M, Simell O, Ilonen J, Vaarala O 2008 Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children.
Hum. Immunol. 69: 108-111.
-
Ajith C, Gupta S, Bhansali A, Radotra BD, Kanwar AJ, Kumar B 2005 Alopecia areata associated with idiopathic primary hypophysitis.
Clin. Exp. Dermatol. 30: 250-252.
*
-
Ajith C, Gupta S, Kanwar AJ 2006 Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in alopecia areata and factors influencing the outcome.
J. Drugs Dermatol. 5: 262-266.
-
Ajuebor MN, Carey JA, Swain MG 2006 CCR5 in T cell-mediated liver diseases: what's going on?
J. Immunol. 177: 2039-2045.
*
-
Akabane H, Miyagawa N, Nii H, Inami Y, Togawa M, Tanaka H, Inagaki N, Nagai H 2004 The effect of a newly synthesized indazole compound, TAS-3-124, on experimental autoimmune disease.
Biol. Pharm. Bull. 27: 1218-1223.
*
-
Akahoshi M, Nakashima H, Shirakawa T 2006 Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus.
Semin. Immunol. 18: 224-229.
*
-
Akamatsu S, Tsukazaki H, Inoue K, Nishio Y 2005 A case of lupus cystitis diagnosed from urinary symptoms as the sole initial complaint.
Hinyokika. Kiyo. 51: 685-687.
-
Akamizu T 1999 Genetic and environmental factors of autoimmune thyroid diseases.
Nippon Rinsho 57: 1697-1702.
-
Akamizu T, Hiratani H, Ikegami S, Rich SS, Bowden DW 2003 Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients.
J. Hum. Genet. 48: 236-242.
*
-
Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW 2000 Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients.
Thyroid 10: 851-858.
-
Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M 2004 Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production.
J. Leukoc. Biol. 76: 227-236.
*
-
Akashi-Takamura S, Miyake K 2006 Toll-like receptors (TLRs) and immune disorders.
J. Infect. Chemother. 12: 233-240.
*
-
Akbar SM, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, Masumoto T, Horiike N, Onji M 2001 Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells.
Eur. J. Clin. Invest. 31: 639-646.
*
-
Akbari O 2006 The role of iNKT cells in development of bronchial asthma: a translational approach from animal models to human.
Allergy 61: 962-968.
*
-
Akcurin S, Turkkahraman D, Tysoe C, Ellard S, De Leener A, Vassart G, Costagliola S 2008 A family with a novel TSH receptor activating germline mutation (p.Ala485Val).
Eur. J. Pediatr. Jan 4 [Epub ahead of print].
*
-
Akella R, Moon TM, Goldsmith EJ 2008 Unique MAP kinase binding sites.
Biochim. Biophys. Acta 1784: 48-55.
*
-
Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M 2002 Environmental factors in the etiology of type 1 diabetes.
Am. J. Med. Genet. 115: 18-29.
-
Akerman L, Mimouni D, David M 2005 Intravenous immunoglobulin for treatment of pemphigus.
Clin. Rev. Allergy Immunol. 29: 289-294.
-
Akerman L, Mimouni D, Trattner A, David M 2006 Pemphigus vulgaris - an alternative for steroid treatment?
Harefuah. 145: 493-494, 551.
-
Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH 2005 An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population.
Arch. Dermatol. Res. 297: 94-98.
*
-
Akhyani M, Chams-Davatchi C, Naraghi Z, Daneshpazhooh M, Toosi S, Asgari M, Malekhami F 2008 Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases.
Br. J. Dermatol. 158: 478-482.
*
-
Akilesh S, Petkova S, Sproule TJ, Shaffer DJ, Christianson GJ, Roopenian D 2004 The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease.
J. Clin. Invest. 113: 1328-1333.
*
-
Akimoto M, Matsushita K, Suruga Y, Aoki N, Ozaki A, Uozumi K, Tei C, Arima N 2007 Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus.
J. Rheumatol. 34: 1841-1848.
-
Akinci A, Cetinkaya E, Aycan Z 2007 Dry eye syndrome in diabetic children.
Eur. J. Ophthalmol. 17: 873-878.
-
Akisawa N, Maeda T, Iwasaki S, Onishi S 1997 Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis.
J. Hepatol. 26: 845-851.
*
-
Akisawa N, Nishimori I, Miyaji E, Iwasaki S, Maeda T, Shimizu H, Sato N, Onishi S 1999 The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients.
J. Gastroenterol. 34: 366-371.
-
Akisu C, Delibas SB, Ozkoc S 2005 Evaluation of three different ELISA kits for the diagnosis of trichinellosis.
Mikrobiyol. Bul. 39: 325-331.
-
Akiyama Y, Tanaka M, Takeishi M, Adachi D, Mimori A, Suzuki T 2000 Clinical, serological and genetic study in patients with CREST syndrome.
Intern. Med. 39: 451-456.
*
-
Akiyoshi F, Sata M, Suzuki H, Uchimura Y, Mitsuyama K, Matsuo K, Tanikawa K 1998 Serum vascular endothelial growth factor levels in various liver diseases.
Dig. Dis. Sci. 43: 41-45.
*
-
Akiyoshi H, Hatakeyama S, Pitkanen J, Mouri Y, Doucas V, Kudoh J, Tsurugaya K, Uchida D, Matsushima A, Oshikawa K, Nakayama KI, Shimizu N, Peterson P, Matsumoto M 2004 Subcellular expression of autoimmune regulator is organized in a spatiotemporal manner.
J. Biol. Chem. 279: 33984-33991.
*
-
Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT 2006 Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
Int. J. Immunogenet. 33: 59-61.
*
-
Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, Abraham SC 2007 Adult autoimmune enteropathy: Mayo Clinic Rochester experience.
Clin. Gastroenterol. Hepatol. 5: 1282-1290.
-
Aksamit AJ 2008 Progressive multifocal leukoencephalopathy.
Curr. Treat. Options Neurol. 10: 178-185.
-
Aksoy DY, Agbaht K, Harmanci O, Karadag O, Aytemir K, Sungur A, Onat AM, Apras S, Yildiz BO, Bayraktar M 2008 Autoimmune polyendocrine syndrome with atrial septal defect.
Am. J. Med. Sci. 335: 157-159.
-
Aksoy DY, Gurlek A, Ringkananont U, Weiss RE, Refetoff S 2005 Resistance to thyroid hormone associated with autoimmune thyroid disease in a Turkish family.
J. Endocrinol. Invest. 28: 379-383.
-
Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I 2007 Rituximab-related viral infections in lymphoma patients.
Leuk. Lymphoma 48: 1307-1312.
-
Aksu G, Ozturk C, Kavakli K, Genel F, Kutukculer N 2007 Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever.
Clin. Rheumatol. 26: 366-370.
*
-
Aktas O, Prozorovski T, Zipp F 2006 Death ligands and autoimmune demyelination.
Neuroscientist 12: 305-316.
*
-
Aktas O, Waiczies S, Zipp F 2007 Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
J. Neuroimmunol. 184: 17-26.
-
Akutsu N, Sakamoto H, Nakagaki T, Sato H, Matsui T, Kobayashi T, Takamura T, Noto H, Katsuramaki T, Hirata K, Imai K, Shinomura Y 2007 A case of alveolar hydatid disease of the liver for which progression was seen on CT images.
Nippon Shokakibyo Gakkai Zasshi 104: 1625-1631.
-
Al Attas RA 2002 How common is celiac disease in Eastern Saudi Arabia?
Ann. Saudi Med. 22: 315-319.
-
Al Khalidi H, Kandel G, Streutker CJ 2006 Enteropathy with loss of enteroendocrine and paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy.
Hum. Pathol. 37: 373-376.
-
Al Shammeri O, Duerksen DR 2008 Celiac crisis in an adult on immunosuppressive therapy.
Can. J. Gastroenterol. 22: 574-576.
-
Al-Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH 2000 Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus.
Tissue Antigens 55: 97-99.
*
-
Al-Awadhi AM, Hasan EA, Sharma PN, Haider MZ, Al-Saeid K 2007 Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis.
Rheumatol. Int. 27: 1119-1123.
*
-
Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A 2008 Frequency of abnormal thyroid function tests in Kuwaiti arabs with autoimmune diseases.
Med. Princ. Pract. 17: 61-65.
-
Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A 2007 Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Singapore Med. J. 48: 847-849.
*
-
Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA 2008 Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.
J. Hepatol. 48: 140-147.
*
-
Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA 2006 Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre.
J. Hepatol. 45: 575-583.
*
-
Al-Chalabi T, Portmann BC, Bernal W, McFarlane IG, Heneghan MA 2008 Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Aliment. Pharmacol. Ther. 28: 209-220.
*
-
Al-Hwiesh AK 2006 Pyoderma gangrenosum in a renal transplant recipient: a case report.
Saudi J. Kidney Dis. Transpl. 17: 559-563.
-
Al-Jabri AA, Al Belushi MS, Nsanze H 2003 Frequency and levels of autoantibodies in healthy adult Omanis.
Ann. Saudi Med. 23: 372-375.
-
Al-Khalidi JA, Czaja AJ 2001 Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis.
Mayo Clin. Proc. 76: 1237-1252.
*
-
Al-Otaibi LM, Porter SR, Poate TW 2005 Behcet's disease: a review.
J. Dent. Res. 84: 209-222.
*
-
Al-Saleh J, el-Eissawy S 2006 The role of T helper cell subsets in pathogenesis of systemic lupus erythematosus and their relation to disease activity.
Egypt J. Immunol. 13: 41-48.
-
Al-Salleeh F, Petro TM 2008 Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages.
J. Immunol. 181: 4523-4533.
-
Al-Toma A, Mulder CJ 2007 Review article: stem cell transplantation for the treatment of gastrointestinal diseases - current applications and future perspectives.
Aliment. Pharmacol. Ther. 26 Suppl. 2: 77-89.
*
-
Al-toma A, Visser OJ, van Roessel HM, von Blomberg BM, Verbeek WH, Scholten PE, Ossenkoppele GJ, Huijgens PC, Mulder CJ 2007 Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T-cells.
Blood 109: 2243-2249.
*
-
Aladag M, Gurakar A, Jalil S, Wright H, Alamian S, Rashwan S, Sebastian A, Nour B 2004 A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: a preliminary report.
Transplant. Proc. 36: 203-205.
*
-
Alaedini A, Green PH 2005 Narrative review: celiac disease: understanding a complex autoimmune disorder.
Ann. Intern. Med. 142: 289-298.
*
-
Alaedini A, Green PH 2008 Autoantibodies in celiac disease.
Autoimmunity 41: 19-26.
-
Alaez C, Loyola M, Murguia A, Flores H, Rodriguez A, Ovilla R, Ignacio G, Amador R, Salinas V, Perez F, Rodriguez D, Morales Z, Llinguin G, Vazquez A, Altamirano A, Gorodezky C 2006 Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity.
Autoimmun. Rev. 5: 167-179.
-
Alaibac M, Berti E, Chizzolini C, Fineschi S, Marzano AV, Pigozzi B, Riboldi E, Sozzani S, Kuhn A 2006 Role of cellular immunity in the pathogenesis of autoimmune skin diseases.
Clin. Exp. Rheumatol. 24: S14-S19.
-
Alajlan A, Alfadley A, Pedersen KT 2002 Transfer of vitiligo after allogeneic bone marrow transplantation.
J. Am. Acad. Dermatol. 46: 606-610.
-
Alansari A, Hajeer A, Teh LS, Bayat A, Mysercough A, Gul A, Inanc M, Ordi-Ros J, Ollier W 2002 Transforming growth factor-12 polymorphism and systemic lupus erythematosus.
J. Rheumatol. 29: 1189-1191.
-
Alarcon-Riquelme ME 2005 The genetics of shared autoimmunity.
Autoimmunity 38: 205-208.
-
Alarcon-Riquelme ME 2006 The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility.
Springer Semin. Immunopathol. 28: 109-117.
*
-
Alarcon-Riquelme ME 2007 Recent advances in the genetics of autoimmune diseases.
Ann. N. Y. Acad. Sci. 1110: 1-9.
-
Alarcon-Riquelme ME 2004 Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.
Arthritis Res. Ther. 6: 169-173.
*
-
Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA 2005 Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort.
Arthritis Rheum. 52: 1138-1147.
*
-
Alard JE, Dueymes M, Youinou P, Jamin C 2007 Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases.
Autoimmun. Rev. 6: 438-443.
-
Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM 2006 Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Diabetes 55: 2098-2105.
*
-
Alavi A, Axford JS 2006 The pivotal nature of sugars in normal physiology and disease.
Wien. Med. Wochenschr. 156: 19-33.
-
Alazmi W, Bustamante M, O'loughlin C, Gonzalez J, Raskin JB 2006 The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis.
Dig. Dis. Sci. 51: 732-736.
*
-
Alba A, Planas R, Clemente X, Carrillo J, Ampudia R, Puertas MC, Pastor X, Tolosa E, Pujol-Borrell R, Verdaguer J, Vives-Pi M 2008 Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.
Clin. Exp. Immunol. 151: 467-475.
*
-
Albarracin F, Meier MJ, Naswetter G, Longoni H. 2008 Hematopoietic stem cell transplantation in autoimmune diseases.
Medicina (B. Aires) 68: 153-163.
-
Albert DA, Albert AN, Vernace M, Sebastian JK, Hsia EC 2005 Analysis of a cluster of cases of Wegener granulomatosis.
J. Clin. Rheumatol. 11: 188-193.
-
Alberti A, Venti M, Biagini S 2008 Headache and cerebral vein and sinus thrombosis.
Front. Neurol. Neurosci. 23: 89-95.
-
Alberti C 2007 Retroperitoneal fibroses: aetiopathogenesis and taxonomic assessment.
Eur. Rev. Med. Pharmacol. Sci. 11: 375-382.
-
Alberti-Flor JJ, Avant GR, Dunn GD 1985 Primary sclerosing cholangitis.
South. Med. J. 78: 173-177.
-
Albilia JB, Lam DK, Blanas N, Clokie CM, Sandor GK 2007 Small mouths ... big problems? A review of scleroderma and its oral health implications.
J. Can. Dent. Assoc. 73: 831-836.
*
-
Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P 2006 Skin involvement and outcome measures in systemic autoimmune diseases.
Clin. Exp. Rheumatol. 24: S52-S59.
-
Albrecht J, Werth VP 2007 Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus.
Dermatol. Ther. 20: 93-101.
-
Albuquerque RV, Hayden CM, Palmer LJ, Laing IA, Rye PJ, Gibson NA, Burton PR, Goldblatt J, Lesouef PN 1998 Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma.
Clin. Exp. Allergy 28: 578-584.
-
Alcaro MC, Papini AM 2006 Contribution of peptides to multiple sclerosis research.
Biopolymers 84: 349-367.
*
-
Alcorta DA, Barnes DA, Dooley MA, Sullivan P, Jonas B, Liu Y, Lionaki S, Reddy CB, Chin H, Dempsey AA, Jennette JC, Falk RJ 2007 Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis.
Kidney Int. 72: 853-864.
-
Aldersley MA, O'Grady JG 1995 Hepatic disorders. Features and appropriate management.
Drugs 49: 83-102.
-
Alderuccio F, Murphy K, Biondo M, Field J, Toh BH 2005 Reversing the autoimmune condition: experience with experimental autoimmune gastritis.
Int. Rev. Immunol. 24: 135-155.
-
Alderuccio F, Toh BH 2004 Induction of tolerance to self-antigens using genetically modified bone marrow cells.
Expert Opin. Biol. Ther. 4: 1007-1014.
-
Aleksandrova EN, Novikov AA, Nasonov EL 2005 Soluble CD40 ligand in autoimmune diseases and atherosclerosis.
Ter. Arkh. 77: 91-95.
-
Aleksic T, Baumann B, Wagner M, Adler G, Wirth T, Weber CK 2007 Cellular immune reaction in the pancreas is induced by constitutively active IKK2.
Gut 56: 227-236.
*
-
Alemany-Rodriguez MJ, Aladro Y, Amela-Peris R, Perez-Vieitez MC, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F 2005 Autoimmune diseases and multiple sclerosis.
Rev. Neurol. 40: 594-597.
-
Alenius GM, Friberg C, Nilsson S, Wahlstrom J, Dahlqvist SR, Samuelsson L 2004 Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis.
J. Rheumatol. 31: 2230-2235.
-
Alessandri C, Bombardieri M, Valesini G 2006 Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.
Adv. Clin. Chem. 42: 297-326.
-
Alessandri C, Priori R, Modesti M, Mancini R, Valesini G 2008 The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis.
Clin. Rev. Allergy Immunol. 34: 45-49.
*
-
Alessandri C, Scrivo R, Spinelli FR, Ceccarelli F, Magrini L, Priori R, Valesini G 2007 Autoantibody production in anti-TNF-alpha-treated patients.
Ann. N. Y. Acad. Sci. 1110: 319-329.
-
Alexander C, Duggleby RC, Goodall JC, Matyszak MK, Telyatnikova N, Gaston JS 2007 Analysis of antigen reactive T-cells.
Methods Mol. Med. 136: 51-68.
-
Alexander JJ, Quigg RJ 2007 Systemic lupus erythematosus and the brain: what mice are telling us.
Neurochem. Int. 50: 5-11.
-
Alexis AF, Dudda-Subramanya R, Sinha AA 2004 Alopecia areata: autoimmune basis of hair loss.
Eur. J. Dermatol. 14: 364-370.
-
Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, Douni E, Blackshear PJ, Kontoyiannis DL, Kollias G 2006 Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity.
Eur. J. Immunol. 36: 2768-2780.
*
-
Alfaro C, Murillo O, Tirapu I, Azpilicueta A, Huarte E, Arina A, Arribillaga L, Perez-Gracia J, Bendandi M, Prieto J, Lasarte J, Melero I 2006 The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases.
An. Sist. Sanit. Navar. 29: 77-96.
-
Ali FR, Larche M 2005 Peptide-based immunotherapy: a novel strategy for allergic disease.
Expert Rev. Vaccines 4: 881-889.
-
Ali HY, Abdullah ZA 2008 Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
J. Immunotoxicol. 5: 173-177.
-
Alidoust L, Zafarghandi M, Agah M, Sendi H, Alavian SM, Zali MR 2007 Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune hepatitis: a case-control study.
Indian J. Gastroenterol. 26: 97-99.
*
-
Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L 2008 Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Am. J. Reprod. Immunol. 60: 229-237.
*
-
Alijotas-Reig J, Garcia-Gimenez V 2008 Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature.
J. Eur. Acad. Dermatol. Venereol. 22: 150-161.
*
-
Alijotas-Reig J, Suy-Franch A, Casellas-Caro M, Vilardell-Tarres M, Cabero-Roura L 2008 Recurrent Kikuchi-Fujimoto necrotizing lymphadenitis during pregnancy.
Eur. J. Obstet. Gynecol. Reprod. Biol. 140: 144-145.
-
Alkaabi JM, Chik CL, Lewanczuk RZ 2008 Pericarditis with cardiac tamponade and Addisonian crisis as the presenting features of autoimmune polyglandular syndrome type II: a case series.
Endocr. Pract. 14: 474-478.
-
Alkari B, Shaath NM, El-Dhuwaib Y, Aboutwerat A, Warnes TW, Chalmers N, Ammori BJ 2005 Transjugular intrahepatic porto-systemic shunt and variceal embolisation in the management of bleeding stomal varices.
Int. J. Colorectal Dis. 20: 457-462.
*
-
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA 2003 Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families.
Pigment Cell Res. 16: 208-214.
*
-
Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, Fox A, Miller C, Dills DG, Ridgway EC, Bennett DC, Fain PR, Spritz RA 2002 Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2.
Hum. Mol. Genet. 11: 661-667.
*
-
Allameh A, Maleklou N, Zargari M, Sanati MH 2008 The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
Neurosci. Lett. 439: 111-115.
-
Allen DB, MacDonald MJ, Gottschall JL, Hunter JB 1989 Autoimmune thyroid phenomena are not evidence for human lymphocyte antigen-genetic heterogeneity in insulin-dependent diabetes.
Am. J. Med. Genet. 33: 405-408.
-
Allen SD, Rawale SV, Whitacre CC, Kaumaya PT 2005 Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
J. Pept. Res. 65: 591-604.
*
-
Alli R, Nguyen P, Geiger TL 2008 Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity.
J. Immunol. 181: 136-145.
-
Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME, Gores GJ, Odin JA 2006 T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.
J. Autoimmun. 27: 232-241.
-
Allina J, Stanca CM, Garber J, Hu B, Sautes-Fridman C, Bach N, Odin JA 2008 Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis.
J. Autoimmun. 30: 238-245.
-
Almeida AR, Legrand N, Papiernik M, Freitas AA 2002 Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.
J. Immunol. 169: 4850-4860.
*
-
Almeida AR, Zaragoza B, Freitas AA 2006 Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells.
J. Immunol. 177: 192-200.
*
-
Almeida PL, Gandolfi L, Modelli IC, Martins RD, Almeida RC, Pratesi R 2008 Prevalence of celiac disease among first degree relatives of Brazilian celiac patients.
Arq. Gastroenterol. 45: 69-72.
*
-
Alnaqdy A, Al-Maskari M 2007 Levels of cytokines and thyroid autoantibodies in Omani patients with Graves' disease.
Br. J. Biomed. Sci. 64: 164-167.
-
Alnounou M, Munoz SJ 2006 Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf]
Practical Gastroenterology April 2006: 92-100. *
-
Alonso A, Bignone ML, Brunzini M, Brunzini R 2006 Ocular autoimmune pemphigoid and cyclosporin A.
Allergol. Immunopathol. (Madr.) 34: 113-115.
-
Alonso A, Hernan MA, Ascherio A 2008 Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis.
Acta Neurol. Scand. 117: 15-20.
*
-
Alonso A, Jick SS, Hernan MA 2006 Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis.
Neurology 66: 572-575.
-
Alonso-Llamazares J, Gibson LE, Rogers RS 3rd 2007 Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience.
Int. J. Dermatol. 46: 910-919.
*
-
Alpdogan O, van den Brink MR 2005 IL-7 and IL-15: therapeutic cytokines for immunodeficiency.
Trends Immunol. 26: 56-64.
*
-
Alpers CE, Smith KD 2008 Cryoglobulinemia and renal disease.
Curr. Opin. Nephrol. Hypertens. 17: 243-249.
-
Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE 2008 Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Ann. Rheum. Dis. 67: 395-401.
-
Alpoz E, Cankaya H, Guneri P 2007 Facial subcutaneous calcinosis and mandibular resorption in systemic sclerosis: a case report.
Dentomaxillofac. Radiol. 36: 172-174.
-
Alpoz E, Guneri P, Onder G, Cankaya H, Kabasakal Y, Kose T 2008 The efficacy of Xialine((R)) in patients with Sjogren's syndrome: a single-blind, cross-over study.
Clin. Oral Investig. 12: 165-172.
*
-
Alpy F, Tomasetto C 2005 Give lipids a START: the StAR-related lipid transfer (START) domain in mammals.
J. Cell. Sci. 118: 2791-2801.
*
-
Alric L, Thebault S, Selves J, Peron JM, Mejdoubi S, Fortenfant F, Vinel JP 2007 Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status.
Gastroenterol. Clin. Biol. 31: 11-16.
*
-
Alsaeid K, Alawadhi A, Al-Saeed O, Haider MZ 2006 Human leukocyte antigen DRB1*04 is associated with rheumatoid arthritis in Kuwaiti patients.
Joint Bone Spine 73: 62-65.
-
Alsaeid K, Haider MZ, Ayoub EM 2003 Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis.
J. Rheumatol. 30: 2705-2709.
-
Altintas A, Cil T, Pasa S, Danis R, Kilinc I, Ayyildiz O, Muftuoglu E 2008 Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
Minerva Med. 99: 7-14.
-
Altintas A, Pasa S, Cil T, Bayan K, Gokalp D, Ayyildiz O 2008 Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura.
Platelets 19: 252-257.
-
Altman A, Szyper-Kravitz M, Shoenfeld Y 2008 HBV vaccine and dermatomyositis: is there an association?
Rheumatol. Int. 28: 609-612.
*
-
Altman A, Uliel L, Caspi L 2008 Dural ectasia as presenting symptom of Marfan syndrome.
Isr. Med. Assoc. J. 10: 194-195.
-
Altmann D 2005 Evaluating the evidence for multiple sclerosis as an autoimmune disease.
Arch. Neurol. 62: 688.
*
-
Altuntas B, Kansu A, Girgin N 1998 Hepatic damage in gluten sensitive enteropathy.
Acta Paediatr. Jpn. 40: 597-599.
-
Alvarez F 2004 Round table: controversies in the treatment of autoimmune liver diseases in children. Cyclosporine indication in “autoimmune hepatitis (AIH)”.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 95-96. *
-
Alvarez F 2004 Clinical and diagnostics aspects in children.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 87-88. *
-
Alvarez F 2006 Autoimmune hepatitis and primary sclerosing cholangitis.
Clin. Liver Dis. 10: 89-107.
-
Alvarez F 2004 Treatment of autoimmune hepatitis: current and future therapies.
Curr. Treat. Options Gastroenterol. 7: 413-420.
-
Alvarez-Baron E, Bien CG, Schramm J, Elger CE, Becker AJ, Schoch S 2008 Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis.
Epilepsy Res. 80: 93-97.
-
Alver A, Mentese A, Karahan SC, Erem C, Keha EE, Arikan MK, Eminagaoglu MS, Deger O 2007 Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease.
Exp. Clin. Endocrinol. Diabetes 115: 287-291.
-
Alves C, Vieira N, Toralles MB, Lyra A 2006 Human histocompatibility system association with gastrointestinal diseases.
Acta Gastroenterol. Latinoam. 36: 86-93.
-
Alves M, Dias AC, Rocha EM 2008 Dry eye in childhood: epidemiological and clinical aspects.
Ocul. Surf. 6: 44-51.
-
Aly T, Devendra D, Eisenbarth GS 2005 Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.
Am. J. Ther. 12: 481-490.
-
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ 2005 Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
J. Autoimmun. 25: S40-S45.
-
Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE 2007 T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.
Nat. Med. 13: 711-718.
*
-
Amagai M 2006 Desmoglein, the target molecule in autoimmunity and infection.
Nihon Rinsho Meneki Gakkai Kaishi 29: 325-333.
-
Amagai M 2008 Pemphigus vulgaris and its active disease mouse model.
Curr. Dir. Autoimmun. 10: 167-181.
-
Amagai M, Ahmed AR, Kitajima Y, Bystryn JC, Milner Y, Gniadecki R, Hertl M, Pincelli C, Fridkis-Hareli M, Aoyama Y, Frusic-Zlotkin M, Muller E, David M, Mimouni D, Vind-Kezunovic D, Michel B, Mahoney M, Grando S 2006 Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'?
Exp. Dermatol. 15: 815.
*
-
Amagai M, Hashimoto T, Kitajima Y 2008 Post-IID 2008 international meeting on autoimmune bullous diseases.
J. Invest. Dermatol. 128: 2135-2137.
*
-
Amakasu H, Kanno A, Abe M 1993 Multiple myeloma occurring in early stage primary biliary cirrhosis.
Tohoku J. Exp. Med. 169: 197-203.
-
Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Coppel RL, Gershwin ME 2004 Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.
J. Immunol. 172: 6444-6452.
*
-
Amano MT, Ferriani VP, Florido MP, Reis ES, Delcolli MI, Azzolini AE, Assis-Pandochi AI, Sjoholm AG, Farah CS, Jensenius JC, Isaac L 2008 Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s gene.
Mol. Immunol. 45: 1693-1702.
*
-
Amarapurkar AD, Amarapurkar DN, Vibhav S, Patel ND 2007 Angiogenesis in chronic liver disease.
Ann. Hepatol. 6: 170-173.
*
-
Amarapurkar DN, Patel ND 2007 Spectrum of autoimmune liver diseases in Western India.
J. Gastroenterol. Hepatol. 22: 2112-2117.
*
-
Amati L, Caradonna L, Jirillo E, Caccavo D 1999 Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
Ital. J. Gastroenterol. Hepatol. 31: 313-325.
-
Amati L, Passeri ME, Resta F, Triggiani V, Jirillo E, Sabba C 2006 Ablation of T-helper 1 cell derived cytokines and of monocyte-derived tumor necrosis factor-alpha in hereditary hemorrhagic telangiectasia: immunological consequences and clinical considerations.
Curr. Pharm. Des. 12: 1201-1208.
-
Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, Covelli V 2006 Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization.
Curr. Pharm. Des. 12: 4247-4254.
-
Ambrogini E, Toraldo G, Marcocci C 2005 Post-menopausal osteoporosis: is it an autoimmune disease?
J. Endocrinol. Invest. 28: S43-S47.
-
Amela-Peris R, Aladro Y, Conde-Sendin MA, Alemany-Rodriguez MJ, Munoz-Fernandez C, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F 2004 Familial multiple sclerosis in Canary Islands.
Rev. Neurol. 39: 911-914.
-
Amend B, Doster H, Lange C, Dubois E, Kalbacher H, Melms A, Bischof F 2006 Induction of autoimmunity by expansion of autoreactive CD4+CD62Llow cells in vivo.
J. Immunol. 177: 4384-4390.
*
-
Amer R, Bamonte G, Forrester JV 2007 Resolution of juvenile idiopathic arthritis-associated uveitis after development of common variable immunodeficiency.
Eur. J. Ophthalmol. 17: 666-668.
-
Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A 2006 Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
Clin. Exp. Dermatol. 31: 746-749.
*
-
Ames PR, Longo UG, Denaro V, Maffulli N 2008 Achilles tendon problems: not just an orthopaedic issue.
Disabil. Rehabil. May 6 [Epub ahead of print].
-
Amicosante M, Fontenot AP 2006 T cell recognition in chronic beryllium disease.
Clin. Immunol. 121: 134-143.
*
-
Amin NM 2008 Antiphospholipid syndromes in infectious diseases.
Hematol. Oncol. Clin. North Am. 22: 131-143.
-
Amirshahrokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M 2008 Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Toxicol. Appl. Pharmacol. Jul 11 [Epub ahead of print].
*
-
Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, Tincani A, Trotta F, Sarzi-Puttini P, Atzeni F 2008 Role of infectious agents in systemic rheumatic diseases.
Clin. Exp. Rheumatol. 26: S27-S32.
-
Ammon HP 2006 Boswellic acids in chronic inflammatory diseases.
Planta Med. 72: 1100-1116.
-
Amos MD, Bridges AJ 2005 Standards for autoantibody testing; addressing future needs for autoimmune disease and cancer diagnosis.
Cancer Biomark. 1: 221-227.
-
Amoura Z, Haroche J, Piette JC 2008 Systemic lupus erythematosus: future therapeutic avenues.
Rev. Med. Interne. 29: 718-724.
-
Amoura Z, Piette JC 2006 New therapeutic approaches to autoimmune diseases.
Presse Med. 35: 709-713.
-
Amoura Z, Piette JC 2006 New therapies for autoimmune diseases.
Rev. Neurol. (Paris) 162 Spec. No. 1: 7-11.
-
Amria S, Hajiaghamohseni LM, Harbeson C, Zhao D, Goldstein O, Blum JS, Haque A 2008 HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.
Eur. J. Immunol. 38: 1961-1970.
*
-
Amroun H, Djoudi H, Busson M, Allat R, El Sherbini SM, Sloma I, Ramasawmy R, Brun M, Dulphy N, Krishnamoorthy R, Toubert A, Charron D, Abbadi MC, Tamouza R 2005 Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism.
Hum. Immunol. 66: 1057-1061.
-
Amu S, Stromberg K, Bokarewa M, Tarkowski A, Brisslert M 2007 CD25-expressing B-lymphocytes in Rheumatic Diseases.
Scand. J. Immunol. 65: 182-191.
*
-
Anagnostopoulos GK, Margantinis G, Tsiakos S, Kostopoulos P, Grigoriadis K, Arvanitidis D 2006 Postinfantile giant-cell hepatitis associated with ulcerative colitis and autoimmune hepatitis.
J. Gastroenterol. Hepatol. 21: 1863-1864.
*
-
Anand AC, Elias E, Neuberger JM 1996 End-stage primary biliary cirrhosis in a first generation migrant south Asian population.
Eur. J. Gastroenterol. Hepatol. 8: 663-666.
-
Anandarajah AP, Schwarz EM 2006 Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications.
J. Cell. Biochem. 97: 226-232.
*
-
Anaya JM 2006 Autoimmunity and autoimmune disease: a Colombian construction beyond deconstructions.
Autoimmun. Rev. 5: 165-166.
-
Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A 2006 Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus.
J. Autoimmun. 26: 208-214.
-
Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G 2002 Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism.
J. Rheumatol. 29: 1874-1876.
-
Anaya JM, Delgado-Vega AM, Castiblanco J 2006 Genetic basis of Sjogren's syndrome. How strong is the evidence?
Clin. Dev. Immunol. 13: 209-222.
-
Anaya JM, Gomez L, Castiblanco J 2006 Is there a common genetic basis for autoimmune diseases?
Clin. Dev. Immunol. 13: 185-195.
*
-
Anaya JM, Shoenfeld Y 2005 Multiple autoimmune disease in a patient with hyperprolactinemia.
Isr. Med. Assoc. J. 7: 740-741.
-
Anaya JM, Tobon GJ, Vega P, Castiblanco J 2006 Autoimmune disease aggregation in families with primary Sjogren's syndrome.
J. Rheumatol. 33: 2227-2234.
-
Anders HJ, Zecher D, Pawar RD, Patole PS 2005 Molecular mechanisms of autoimmunity triggered by microbial infection.
Arthritis Res. Ther. 7: 215-224.
*
-
Andersen MH, Schrama D, Thor Straten P, Becker JC 2006 Cytotoxic T cells.
J. Invest. Dermatol. 126: 32-41.
*
-
Andersen-Ranberg K, HOier-Madsen M, Wiik A, Jeune B, Hegedus L 2004 High prevalence of autoantibodies among Danish centenarians.
Clin. Exp. Immunol. 138: 158-163.
*
-
Anderson AC, Anderson DE 2006 TIM-3 in autoimmunity.
Curr. Opin. Immunol. 18: 665-669.
-
Anderson AC, Reddy J, Nazareno R, Sobel RA, Nicholson LB, Kuchroo VK 2004 IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice.
J. Immunol. 173: 828-834.
*
-
Anderson DE 2007 TIM-3 as a therapeutic target in human inflammatory diseases.
Expert Opin. Ther. Targets 11: 1005-1009.
-
Anderson DE, Sharpe AH, Hafler DA 1999 The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system.
Curr. Opin. Immunol. 11: 677-683.
-
Anderson DW 2001 Cytokines as drug targets.
IDrugs 4: 375-377.
-
Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, Franklin RJ, Giovannoni G, Compston DA, Baker D, Spillantini MG, Chandran S 2008 Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.
Brain 131: 1736-1748.
-
Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B 2006 Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.
Behav. Brain Res. 166: 32-38.
*
-
Anderson MS, Bluestone JA 2005 The NOD mouse: a model of immune dysregulation.
Annu. Rev. Immunol. 23: 447-485.
*
-
Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D 2005 The cellular mechanism of Aire control of T cell tolerance.
Immunity 23: 227-239.
*
-
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D 2002 Projection of an immunological self shadow within the thymus by the aire protein.
Science 298: 1395-1401.
*
-
Anderson P, Delgado M 2008 Endogenous anti-inflammatory neuropeptides and proresolving lipid mediators: a new therapeutic approach for immune disorders.
J. Cell. Mol. Med. Jun 12 [Epub ahead of print].
*
-
Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA 2004 Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis.
Ann. Neurol. 55: 654-659.
*
-
Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallstrom E, Lobell A, Brundin L, Lassmann H, Harris RA 2008 Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.
J. Leukoc. Biol. Jul 21 [Epub ahead of print].
*
-
Andersson A, Holmdahl R 2005 A genetic basis for shared autoimmunity in mouse models.
Autoimmunity 38: 209-217.
-
Andersson A, Kokkola R, Wefer J, Erlandsson-Harris H, Harris RA 2004 Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility.
J. Leukoc. Biol. 76: 1118-1124.
*
-
Andersson EC, Svendsen P, Svejgaard A, Holmdahl R, Fugger L 2000 A molecule basis for the HLA association in rheumatoid arthritis.
Rev. Immunogenet. 2: 81-87.
-
Andersson G, Svensson AC, Setterblad N, Rask L 1998 Retroelements in the human MHC class II region.
Trends Genet. 14: 109-114.
*
-
Anderton SM 2006 Avoiding autoimmune disease - T cells know their limits.
Trends Immunol. 27: 208-214.
*
-
Ando T, Latif R, Davies TF 2007 Antibody-induced modulation of TSH receptor post-translational processing.
J. Endocrinol. 195: 179-186.
*
-
Andreas K, Luebke C, Haeupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M 2008 Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study.
Arthritis Res. Ther. 10: R9.
*
-
Andren M, Johanneson B, Alarcon-Riquelme ME, Kleinau S 2005 IgG Fc receptor polymorphisms and association with autoimmune disease.
Eur. J. Immunol. 35: 3020-3029.
*
-
Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, Radice A, Corace C, Sinico RA, Meroni PL, Tincani A 2008 Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity?
J. Autoimmun. 30: 50-56.
*
-
Andres D, Bautista M, Cascales M 2005 Attenuation of cyclosporine A toxicity by sublethal heat shock. Role of catalase.
Biochem. Pharmacol. 69: 493-501.
*
-
Andresen H, Zarse K, Grotzinger C, Hollidt JM, Ehrentreich-Forster E, Bier FF, Kreuzer OJ 2006 Development of peptide microarrays for epitope mapping of antibodies against the human TSH receptor.
J. Immunol. Methods 315: 11-18.
*
-
Andryushkova AA, Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsky GA 2006 Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice.
FEBS Lett. 580: 5089-5095.
*
-
Anel A, Bosque A, Naval J, Pineiro A, Larrad L, Alava MA, Martinez-Lorenzo MJ 2007 Apo2L/TRAIL and immune regulation.
Front. Biosci. 12: 2074-2084.
-
Ang CW, Jacobs BC, Laman JD 2004 The Guillain-Barre syndrome: a true case of molecular mimicry.
Trends Immunol. 25: 61-66.
*
-
Ang DK, Brodnicki TC, Jordan MA, Wilson WE, Silveira P, Gliddon BL, Baxter AG, van Driel IR 2007 Two genetic loci independently confer susceptibility to autoimmune gastritis.
Int. Immunol. 19: 1135-1144.
-
Angelo Ghezzi A, Zaffaroni M 2008 Female-specific issues in multiple sclerosis.
Expert Rev. Neurother. 8: 969-977.
-
Angelo LS, Kurzrock R 2007 Vascular endothelial growth factor and its relationship to inflammatory mediators.
Clin. Cancer Res. 13: 2825-2830.
*
-
Angulo P 2002 Treatment of nonalcoholic fatty liver disease.
Ann. Hepatol. 1: 12-19.
*
-
Angulo P 2002 Use of ursodeoxycholic acid in patients with liver disease.
Curr. Gastroenterol. Rep. 4: 37-44.
-
Angulo P, El-Amin O, Carpenter HA, Lindor KD 2001 Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis.
Am. J. Gastroenterol. 96: 3021-3027.
*
-
Angulo P, Lindor KD 1999 Primary biliary cirrhosis and primary sclerosing cholangitis.
Clin. Liver Dis. 3: 529-570.
*
-
Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD 2000 Serum autoantibodies in patients with primary sclerosing cholangitis.
J. Hepatol. 32: 182-187.
*
-
Angyal A, Prechl J, Sarmay G 2007 Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases.
Expert Opin. Biol. Ther. 7: 691-704.
-
Anijeet DR, Graham C, Khooshabeh R 2006 Giant cell arteritis-part of a spectrum of autoimmune disease?
Eye 20: 1434-1435.
-
Anjiki N, Hoshino R, Ohnishi Y, Hioki K, Irie Y, Ishige A, Watanabe K 2005 A kampo formula Juzen-taiho-to induces expression of metallothioneins in mice.
Phytother. Res. 19: 915-917.
*
-
Anjos SM, Shao W, Marchand L, Polychronakos C 2005 Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' +6230G>A polymorphism.
Genes Immun. 6: 305-311.
*
-
Anjuere F, Czerkinsky C 2007 Mucosal immunity and vaccine development.
Med. Sci. (Paris) 23: 371-378.
-
Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S 2007 Phenotypic and functional features of human Th17 cells.
J. Exp. Med. 204: 1849-1861.
*
-
Anolik J, Sanz I 2004 B cells in human and murine systemic lupus erythematosus.
Curr. Opin. Rheumatol. 16: 505-512.
-
Anolik JH, Aringer M 2005 New treatments for SLE: cell-depleting and anti-cytokine therapies.
Best Pract. Res. Clin. Rheumatol. 19: 859-878.
-
Ansari AA 2004 Autoimmunity, anergy, lentiviral immunity and disease.
Autoimmun. Rev. 3: 530-540.
-
Ansari AW, Heiken H, Moenkemeyer M, Schmidt RE 2007 Dichotomous effects of C-C chemokines in HIV-1 pathogenesis.
Immunol. Lett. 110: 1-5.
-
Ansari MJ, Sayegh MH 2006 Costimulation couture: a designer approach to regulating autoimmunity.
J. Clin. Invest. 116: 2080-2083.
*
-
Ansarian HR, Derakhshan M, Takafuji M, Ihara H 2008 The impact of supramolecular chemistry in medicine: removing the border between infectious and non-infectious diseases.
Med. Hypotheses Aug 31 [Epub ahead of print].
-
Anstey A, Lear JT 1998 Azathioprine: clinical pharmacology and current indications in autoimmune disorders.
BioDrugs 9: 33-47.
-
Antar M, Lamarche J, Peguero A, Reiss A, Cole S 2008 A case of selective immunoglobulin M deficiency and autoimmune glomerulonephritis.
Clin. Exp. Nephrol. 12: 300-304.
-
Antonelli A, Ferri C, Fallahi P, Colaci M, Giuggioli D, Ferrari SM, Frascerra S, Franzoni F, Galetta F, Ferrannini E 2008 Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis.
J. Rheumatol. 35: 1809-1811.
-
Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Carpi A, Nicolini A, Ferrannini E 2008 Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.
Metabolism 57: 1270-1277.
*
-
Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P 2008 Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.
Autoimmun. Rev. Aug 12 [Epub ahead of print].
-
Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, Menegatti E, Olivieri I, Puoti M, Palazzi C, Roccatello D, Vergani D, Sarzi-Puttini P, Atzeni F 2008 HCV infection: pathogenesis, clinical manifestations and therapy.
Clin. Exp. Rheumatol. 26: S39-S47.
-
Antonelli A, Rotondi M, Fallahi P, Grosso M, Boni G, Ferrari SM, Romagnani P, Serio M, Mariani G, Ferrannini E 2007 Iodine-131 given for therapeutic purposes modulates differently interferon-gamma inducible alpha chemokine CXCL10 serum levels in patients with active Graves' disease or with toxic nodular goiter.
J. Clin. Endocrinol. Metab. 92: 1485-1490.
*
-
Antonijevic IA 2005 Depressive disorders - is it time to endorse different pathophysiologies?
Psychoneuroendocrinology 31: 1-15.
*
-
Antonio M, Patrizia F, Ilaria I, Paolo F 2008 A rational approach on the use of sex steroids in multiple sclerosis.
Recent Patents CNS Drug Discov. 3: 34-39.
-
Antoniu SA 2006 Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting?
Expert Opin. Investig. Drugs 15: 181-184.
-
Antoniu SA 2007 Treatment options for refractory Wegener's granulomatosis: a role for rituximab?
Curr. Opin. Investig. Drugs 8: 927-932.
-
Antonucci A, Negosanti M, Tabanelli M, Varotti C 2007 Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): five cases.
J. Dermatolog. Treat. 18: 178-183.
-
Antony JM, Ellestad KK, Hammond R, Imaizumi K, Mallet F, Warren KG, Power C 2007 The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes.
J. Immunol. 179: 1210-1224.
*
-
Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S 2004 Liver involvement in primary Sjogren's syndrome.
Nihon Rinsho Meneki Gakkai Kaishi 27: 397-401.
-
Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, Gershwin ME 2005 Transforming growth factor beta (TGF-beta) and autoimmunity.
Autoimmun. Rev. 4: 450-459.
-
Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA, Gershwin ME 2005 NOD mice and autoimmunity.
Autoimmun. Rev. 4: 373-379.
-
Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME 2006 IL-2 receptor alpha deficiency and features of primary biliary cirrhosis.
J. Autoimmun. 27: 50-53.
-
Aoki S, Nakazawa T, Ohara H, Sano H, Nakao H, Joh T, Murase T, Eimoto T, Itoh M 2005 Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera.
Histopathology 47: 147-158.
*
-
Aoki V, Millikan RC, Rivitti EA, Hans-Filho G, Eaton DP, Warren SJ, Li N, Hilario-Vargas J, Hoffmann RG, Diaz LA; Cooperative Group for Fogo Selvagem Research 2004 Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem).
J. Investig. Dermatol. Symp. Proc. 9: 34-40.
*
-
Aoki-Ota M, Kinoshita M, Ota T, Tsunoda K, Iwasaki T, Tanaka S, Koyasu S, Nishikawa T, Amagai M 2006 Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model.
J. Invest. Dermatol. 126: 105-113.
*
-
Aoun NY, Velez E, Aggarwal A, Hayes GB, Kenney LA 2004 Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man.
Respir. Care 49: 1515-1521.
*
-
Aoyama H, Hirata T, Sakugawa H, Watanabe T, Miyagi S, Maeshiro T, Chinen T, Kawane M, Zaha O, Nakayoshi T, Kinjo F, Fujita J 2007 An inverse relationship between autoimmune liver diseases and Strongyloides stercoralis infection.
Am. J. Trop. Med. Hyg. 76: 972-976.
-
Aoyama H, Sakugawa H, Nakasone H, Nakayoshi T, Kinjo A, Tamayose M, Higa H, Uema E, Chinen T, Tomiyama R, Uchima N, Kugai Y, Kinjo F, Saito A, Kinjo M 2002 A rare association of primary biliary cirrhosis and pernicious anemia.
J. Gastroenterol. 37: 560-563.
*
-
Apenteng T, Kaplan B, Meyers K 2006 Renal outcomes in children with lupus and a family history of autoimmune disease.
Lupus 15: 65-70.
-
Apiratpracha W, Ho JK, Powell JJ, Yoshida EM 2006 Acute lower gastrointestinal bleeding from a dieulafoy lesion proximal to the anorectal junction post-orthotopic liver transplant.
World J. Gastroenterol. 12: 7547-7548.
*
-
Apostolopoulos J, Ooi JD, Odobasic D, Holdsworth SR, Kitching AR 2006 The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease.
J. Immunol. Methods 308: 167-178.
*
-
Appenzeller S, Fattori A, Saad ST, Costallat LT 2008 Systemic lupus erythematosus in patients with sickle cell disease.
Clin. Rheumatol. 27: 359-364.
*
-
Appleby MW, Ramsdell F 2008 Scurfy, the Foxp3 locus, and the molecular basis of peripheral tolerance.
Curr. Top. Microbiol. Immunol. 321: 151-168.
-
Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, Rifkin IR, Walsh K 2006 Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.
J. Immunol. 177: 3028-3034.
*
-
Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC 2004 Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis.
J. Clin. Gastroenterol. 38: 805-809.
-
Arabi MA, Nouri-Aria KT, Alexander GJ, Eddleston AL, Williams R 1985 Concanavalin A induced suppression of lymphocyte proliferation in chronic liver disease. A study of suppressor and responder populations in autologous and allogeneic systems.
J. Clin. Lab. Immunol. 18: 161-165.
-
Arafat HA, Lada E, Katakam AK, Amin N 2006 Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Exp. Clin. Endocrinol. Diabetes 114: 555-562.
-
Arai O, Matsueda K, Katayama S, Hirao K, Miyoshi M, Mouri H, Notohara K, Yamamoto H 2008 A case of autoimmune pancreatitis with various extrapancreatic fibrosclerosis followed by malignant diseases.
Nippon Shokakibyo Gakkai Zasshi 105: 711-718.
-
Arakaki O, Yamamoto Y, Awazawa R, Nonaka K, Taira K, Asato Y, Hagiwara K, Oyama B, Ishii N, Hashimoto T, Uezato H 2008 Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia.
J. Dermatol. 35: 437-446.
-
Arakawa Y, Amaki S, Miyakawa H, Sakai T, Gotou I, Tanaka N, Moriyama M, Iwasaki A, Sugitani M, Arakawa Y 2004 PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
J. Gastroenterol. 39: 490-495.
*
-
Arakawa Y, Hashida N, Ohguro N, Yamazaki N, Onda M, Matsumoto S, Ohishi M, Yamabe K, Tano Y, Kurokawa N 2008 Eye-concentrated distribution of dexamethasone carried by sugar-chain modified liposome in experimental autoimmune uveoretinitis mice.
Biomed. Res. 28: 331-334.
-
Aranami T, Miyake S, Yamamura T 2006 Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis.
J. Immunol. 177: 5659-5667.
*
-
Aranami T, Yamamura T 2008 Th17 cells and autoimmune encephalomyelitis (EAE/MS).
Allergol. Int. 57: 115-120.
*
-
Arash A, Shirin L 2008 The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid.
J. Oral Pathol. Med. 37: 341-344.
-
Arason GJ 2008 The association of complement with common connective tissue diseases - a review.
Laeknabladid. 94: 371-374.
-
Arason GJ, Kolka R, Hreidarsson AB, Gudjonsson H, Schneider PM, Fry L, Arnason A 2005 Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
Clin. Exp. Immunol. 140: 572-579.
*
-
Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, Morato MJ, Correa-Oliveira R 2007 Potential role of CD4+CD25high regulatory T cells in morbidity in Chagas disease.
Front. Biosci. 12: 2797-2806.
-
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S 2007 Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents.
Hum. Immunol. 68: 739-743.
-
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S 2008 Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes.
Pediatr. Diabetes 9: 272-276.
-
Arbour L, Field L, Ross P, Erikson A, Yoshida E 2004 The mystery of primary biliary cirrhosis in British Columbia's First Nations people.
Int. J. Circumpolar Health 63 Suppl. 2: 185-188.
*
-
Arbour L, Rupps R, Field L, Ross P, Erikson A, Henderson H, Hill W, Yoshida E 2005 Characteristics of primary biliary cirrhosis in British Columbia's First Nations population.
Can. J. Gastroenterol. 19: 305-310.
-
Arbour N, Lapointe R, Saikali P, McCrea E, Regen T, Antel JP 2006 A new clinically relevant approach to expand myelin specific T cells.
J. Immunol. Methods 310: 53-61.
*
-
Arcavi M, Orfus G 2006 Prevalence of antinuclear envelope antibodies and their isotypes in sera positive for antinuclear antibodies.
Medicina (B. Aires) 66: 327-331.
-
Ardesjo B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kampe O, Ekwall O 2008 Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
J. Autoimmun. 30: 273-282.
-
Ardizzone S, Puttini PS, Cassinotti A, Porro GB 2008 Extraintestinal manifestations of inflammatory bowel disease.
Dig. Liver Dis. 40 Suppl. 2: S253-S259.
-
Ardoin SP, Pisetsky DS 2008 The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation.
Mod. Rheumatol. 18: 319-326.
*
-
Arenas F, Hervias I, Uriz M, Joplin R, Prieto J, Medina JF 2008 Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
J. Clin. Invest. 118: 695-709.
*
-
Arends J, Wu J, Borillo J, Troung L, Zhou C, Vigneswaran N, Lou YH 2006 T cell epitope mimicry in antiglomerular basement membrane disease.
J. Immunol. 176: 1252-1258.
*
-
Argueta JG, Shiota S, Yamaguchi N, Masuhiro Y, Hanazawa S 2006 Induction of Porphyromonas gingivalis GroEL signaling via binding to Toll-like receptors 2 and 4.
Oral. Microbiol. Immunol. 21: 245-251.
*
-
Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP 1997 Tumor necrosis factor-alpha gene polymorphism in psoriasis.
Exp. Clin. Immunogenet. 14: 118-122.
-
Aribi M 2008 Candidate genes implicated in type 1 diabetes susceptibility.
Curr. Diabetes Rev. 4: 110-121.
-
Aricha R, Feferman T, Fuchs S, Souroujon MC 2008 Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
J. Immunol. 180: 2132-2139.
-
Aries PM, Hellmich B, Gross WL 2005 Intravenous immunoglobulin therapy in vasculitis: speculation or evidence?
Clin. Rev. Allergy Immunol. 29: 237-246.
-
Aries PM, Witte T, Lamprecht P 2007 Report on the 34th Meeting of the German Clinical Immunology Workgroup, Frankfurt, 03.-04.11.2006.
Z. Rheumatol. 66: 63-64.
-
Arii K, Kumon Y, Sugahara K, Nakatani K, Ikeda Y, Suehiro T, Hashimoto K 2008 Edaravone inhibits collagen-induced arthritis possibly through suppression of nuclear factor-kappa B.
Mol. Immunol. 45: 463-469.
*
-
Arisawa EA, Almeida JD, Carvalho YR, Cabral LA 2008 Clinicopathological analysis of oral mucous autoimmune disease: a 27-year study.
Med. Oral Patol. Oral Cir. Bucal. 13: E94-E97.
-
Arkfeld DG 2008 The potential utility of B cell-directed biologic therapy in autoimmune diseases.
Rheumatol. Int. 28: 205-215.
*
-
Arkkila PE 2006 Thromboangiitis obliterans (Buerger's disease).
Orphanet J. Rare Dis. 1: 14.
*
-
Arkwright PD, Abinun M, Cant AJ 2002 Autoimmunity in human primary immunodeficiency diseases.
Blood 99: 2694-2702.
*
-
Armagan O, Ekim A, Dinc A, Oner C 2007 Ankylosing spondylitis in a patient with Turner syndrome: a case report.
Rheumatol. Int. 27: 1177-1180.
*
-
Armengol MP, Sabater L, Fernandez M, Ruiz M, Alonso N, Otero MJ, Martínez-Caceres E, Jaraquemada D, Pujol-Borrell R 2008 Influx of recent thymic emigrants into autoimmune thyroid disease glands in humans.
Clin. Exp. Immunol. Jul 11 [Epub ahead of print].
-
Armentano F, Knight T, Makker S, Tramontano A 2006 Induction of covalent binding antibodies.
Immunol. Lett. 103: 51-57.
-
Armstrong VW, Shipkova M, von Ahsen N, Oellerich M 2004 Analytic aspects of monitoring therapy with thiopurine medications.
Ther. Drug Monit. 26: 220-226.
-
Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL 1996 Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome.
Eur. J. Immunogenet. 23: 211-219.
-
Arnett FC 2000 Genetic studies of human lupus in families.
Int. Rev. Immunol. 19: 297-317.
-
Arnett HA, Viney JL 2007 Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
Adv. Drug Deliv. Rev. 59: 1084-1092.
-
Arnon R, Aharoni R 2007 Neurogenesis and neuroprotection in the CNS - fundamental elements in the effect of glatiramer acetate on treatment of autoimmune neurological disorders.
Mol. Neurobiol. 36: 245-253.
-
Aroeira LS 2006 TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
Clin. Immunol. 119: 252-260.
*
-
Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D 1999 HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype.
Am. J. Respir. Crit. Care Med. 159: 1464-1468.
*
-
Aron-Maor A, Shoenfeld Y 2001 Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.
Lupus 10: 237-240.
-
Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N 2004 Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Mol. Immunol. 41: 449-456.
*
-
Arostegui JI, Solis P, Aldea A, Cantero T, Rius J, Bahillo P, Plaza S, Vives J, Gomez S, Yague J 2005 Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.
Eur. J. Pediatr. 164: 13-16.
*
-
Arostegui JI, Yague J 2008 Hereditary systemic autoinflammatory diseases. Part II: cryopyrin-associated periodic syndromes, pediatric systemic granulomatosis and PAPA syndrome.
Med. Clin. (Barc.) 130: 429-438.
-
Arranz A, Abad C, Juarranz Y, Torroba M, Rosignoli F, Leceta J, Gomariz RP, Martinez C 2006 Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.
Ann. N. Y. Acad. Sci. 1070: 129-134.
*
-
Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martinez C 2008 VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
Peptides 29: 948-956.
*
-
Arrue I, Saiz A, Ortiz-Romero PL, Rodriguez-Peralto JL 2007 Lupus-like reaction to interferon at the injection site: report of five cases.
J. Cutan. Pathol. 34 Suppl. 1: 18-21.
-
Arruvito L, Sanz M, Banham AH, Fainboim L 2007 Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction.
J. Immunol. 178: 2572-2578.
*
-
Arthur AT, Armati PJ, Bye C, Consortium SM, Heard RN, Stewart GJ, Pollard JD, Booth DR 2008 Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.
BMC Med. Genet. 9: 17.
*
-
Artis D, Grencis RK 2008 The intestinal epithelium: sensors to effectors in nematode infection.
Mucosal Immunol. 1: 252-264. *
-
Artlett CM 2002 Microchimerism in health and disease.
Curr. Mol. Med. 2: 525-535.
-
Artlett CM, O'Hanlon TP, Lopez AM, Song YW, Miller FW, Rider LG 2003 HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Arthritis Rheum. 48: 2567-2572.
*
-
Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP, Taylor SM 2008 Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.
Neuroscience Jul 12 [Epub ahead of print].
-
Aruna BV, Ben-David H, Sela M, Mozes E 2006 A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
Immunology 118: 413-424.
*
-
Aruna BV, Sela M, Mozes E 2005 Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells.
Proc. Natl. Acad. Sci. U.S.A. 102: 10285-10290.
*
-
Arundel C, Lewis JH 2007 Drug-induced liver disease in 2006.
Curr. Opin. Gastroenterol. 23: 244-254.
-
Arzoo K, Sadeghi S, Liebman HA 2002 Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab).
Ann. Rheum. Dis. 61: 922-924.
*
-
Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, Okamoto K, Nishikawa K, Latz E, Golenbock DT, Aoki K, Ohya K, Imai Y, Morishita Y, Miyazono K, Kato S, Saftig P, Takayanagi H 2008 Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis.
Science 319: 624-627.
*
-
Asahina A, Fujita H, Fukunaga Y, Kenmochi Y, Ikenaka T, Mitomi H 2007 Early lesion of palisaded neutrophilic granulomatous dermatitis in ulcerative colitis.
Eur. J. Dermatol. 17: 234-237.
-
Asarch A, Barak O, Loo DS, Gottlieb AB 2008 Th17 cells: a new therapeutic target in inflammatory dermatoses.
J. Dermatolog. Treat. Jul 14 [Epub ahead of print].
-
Asashima N, Fujimoto M, Watanabe R, Nakashima H, Yazawa N, Okochi H, Tamaki K 2006 Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Br. J. Dermatol. 155: 330-336.
*
-
Aseni P, Di Sandro S, Mihaylov P, Lamperti L, De Carlis LG 2008 Atypical presentation of pioderma gangrenosum complicating ulcerative colitis: rapid disappearance with methylprednisolone.
World J. Gastroenterol. 14: 5471-5473.
-
Asero R, Riboldi P, Tedeschi A, Cugno M, Meroni P 2007 Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation.
Autoimmun. Rev. 7: 71-76.
-
Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, Motoyama S, Nakago S, Barlow D, Maruo T 2004 The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population.
Hum. Reprod. 19: 2509-2514.
*
-
Asherson RA 2005 Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.
Immunobiology 210: 727-733.
*
-
Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A 2006 The antiphospholipid antibody syndrome: diagnosis, skin.
Clin. Exp. Rheumatol. 24: S46-S51.
-
Asherson RA, Gunter K, Daya D, Shoenfeld Y 2008 Multiple autoimmune diseases in a young woman: tuberculosis and splenectomy as possible triggering factors? Another example of the "mosaic" of autoimmunity.
J. Rheumatol. 35: 1224-1226.
-
Ashfield R, Jakobsen BK 2006 Making high-affinity T-cell receptors: a new class of targeted therapeutics.
IDrugs 9: 554-559.
-
Ashizawa T, Matsuno N, Yokoyama T, Kihara Y, Kuzuoka K, Taira S, Konno O, Jyojima Y, Akashi I, Nakamura Y, Hama K, Iwamoto H, Iwahori T, Nagao T, Kasahara M, Tanaka K 2006 The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
Transplant. Proc. 38: 3629-3632.
*
-
| |
